• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测肝细胞癌预后的免疫相关微小RNA特征的鉴定与验证

Identification and validation of an immune-related miRNA signature for predicting prognosis of hepatocellular carcinoma.

作者信息

Hu Tao, Gu Jiarong, Tan Lin, Deng Haiyan, Gao Xianxian, Yang Shanru, Xu Hao, Hou Xin, Liao Qi, Yang Xiaoping

机构信息

Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315010, PR China.

School of Public Health, Ningxia Medical University, Yinchuan, Ningxia, PR China; Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, PR China.

出版信息

Int Immunopharmacol. 2025 Jan 27;146:113850. doi: 10.1016/j.intimp.2024.113850. Epub 2024 Dec 16.

DOI:10.1016/j.intimp.2024.113850
PMID:39689603
Abstract

MicroRNAs play a significant role in the initiation and progression of hepatocellular carcinoma (HCC); however, their roles in immune regulation of HCC remain unclear. Our study aimed to identify an immune-related miRNA signature and explore its impact on the prognosis and tumor immune microenvironment HCC. Initially, we identified 48 differentially expressed immune-related miRNAs. Using the LASSO regression dimensionality reduction method, we constructed an immune-related miRNA signature from 12 of these miRNAs. This signature has emerged as an independent prognostic marker and is associated with the clinical stage of HCC. To elucidate the roles of the twelve-microRNA signature, we predicted their target genes. Enrichment analysis indicated that these target genes were involved in immune cell infiltration. Notably, the target genes regulated by hsa-miR-139-5p, hsa-miR-551a, and hsa-miR-7-5p showed a partial overlap. We further confirmed the differential expression of miR-7, miR-551a, miR-139-5p, and some of their overlapping target genes in tumor and non-tumor tissues derived from patients with HCC using RT-qPCR. Overall, we identified an immune-related miRNA signature that is strongly correlated with the prognosis and immune microenvironment of HCC; and confirmed the differential expression of the three most important microRNAs and their overlapping target genes in tumor and non-tumor tissues derived from HCC patients.

摘要

微小RNA在肝细胞癌(HCC)的发生和发展中起重要作用;然而,它们在HCC免疫调节中的作用仍不清楚。我们的研究旨在识别一种与免疫相关的微小RNA特征,并探讨其对HCC预后和肿瘤免疫微环境的影响。最初,我们鉴定出48种差异表达的免疫相关微小RNA。使用套索回归降维方法,我们从其中12种微小RNA构建了一种与免疫相关的微小RNA特征。该特征已成为一个独立的预后标志物,并与HCC的临床分期相关。为了阐明这12种微小RNA特征的作用,我们预测了它们的靶基因。富集分析表明这些靶基因参与免疫细胞浸润。值得注意的是,由hsa-miR-139-5p、hsa-miR-551a和hsa-miR-7-5p调控的靶基因存在部分重叠。我们使用RT-qPCR进一步证实了miR-7、miR-551a、miR-139-5p及其一些重叠靶基因在HCC患者肿瘤和非肿瘤组织中的差异表达。总体而言,我们识别出一种与HCC预后和免疫微环境密切相关的免疫相关微小RNA特征;并证实了三种最重要的微小RNA及其重叠靶基因在HCC患者肿瘤和非肿瘤组织中的差异表达。

相似文献

1
Identification and validation of an immune-related miRNA signature for predicting prognosis of hepatocellular carcinoma.用于预测肝细胞癌预后的免疫相关微小RNA特征的鉴定与验证
Int Immunopharmacol. 2025 Jan 27;146:113850. doi: 10.1016/j.intimp.2024.113850. Epub 2024 Dec 16.
2
Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma.免疫相关 microRNA 特征可预测肝细胞癌的预后和免疫微环境。
Life Sci. 2021 Jan 15;265:118799. doi: 10.1016/j.lfs.2020.118799. Epub 2020 Nov 19.
3
Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.构建并验证三 miRNA 标志物作为肝癌患者的预后生物标志物。
Int J Med Sci. 2021 Jan 1;18(4):984-999. doi: 10.7150/ijms.49126. eCollection 2021.
4
The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.鉴定 N6-甲基腺苷相关的 microRNA 预测肝细胞癌的预后和免疫治疗疗效。
Cancer Biomark. 2023;38(4):551-566. doi: 10.3233/CBM-230263.
5
A Novel Prognostic Immune-related Gene Signature in Hepatocellular Carcinoma Through Bioinformatics and Experimental Approaches.通过生物信息学和实验方法建立的肝细胞癌新型预后免疫相关基因特征
Iran J Allergy Asthma Immunol. 2024 Dec 29;23(6):699-726. doi: 10.18502/ijaai.v23i6.17380.
6
Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.肝细胞癌相关的微小RNA表达特征:综合生物信息学分析、实验验证及临床意义
Oncotarget. 2015 Sep 22;6(28):25093-108. doi: 10.18632/oncotarget.4437.
7
A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.一种用于肝细胞癌诊断和预后的新型微小RNA表达特征。
Oncotarget. 2017 Jan 31;8(5):8775-8784. doi: 10.18632/oncotarget.14452.
8
Multi-omics identification of a polyamine metabolism related signature for hepatocellular carcinoma and revealing tumor microenvironment characteristics.多组学鉴定肝细胞癌中与多胺代谢相关的特征并揭示肿瘤微环境特征
Front Immunol. 2025 Apr 22;16:1570378. doi: 10.3389/fimmu.2025.1570378. eCollection 2025.
9
Expression of lipid-metabolism genes is correlated with immune microenvironment and predicts prognosis of hepatocellular carcinoma.脂质代谢基因的表达与免疫微环境相关,并可预测肝细胞癌的预后。
Sci Rep. 2024 Oct 28;14(1):25705. doi: 10.1038/s41598-024-76578-5.
10
Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.基于生物信息学分析乙型肝炎病毒相关性肝细胞癌中潜在的 miRNA-mRNA 调控轴。
Int J Med Sci. 2021 Jan 1;18(2):335-346. doi: 10.7150/ijms.50126. eCollection 2021.

引用本文的文献

1
Exploring microRNA targeting as a promising approach for solid tumor treatment.探索将微小RNA靶向作为实体瘤治疗的一种有前景的方法。
Front Oncol. 2025 Jul 21;15:1570093. doi: 10.3389/fonc.2025.1570093. eCollection 2025.
2
A novel miRNA-based model for predicting the 3-year recurrence risk of hepatocellular carcinoma following liver transplantation.一种基于微小RNA的新型模型,用于预测肝移植后肝细胞癌的3年复发风险。
J Gastrointest Oncol. 2025 Jun 30;16(3):1208-1219. doi: 10.21037/jgo-2025-9. Epub 2025 Jun 27.